1.Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes.
Kyoung Soo KIM ; Da Hee OH ; Jung Yeon KIM ; Bong Gn LEE ; Jeong Soon YOU ; Kyung Ja CHANG ; Hyunju CHUNG ; Myung Chul YOO ; Hyung In YANG ; Ja Heon KANG ; Yoo Chul HWANG ; Kue Jeong AHN ; Ho Yeon CHUNG ; In Kyung JEONG
Experimental & Molecular Medicine 2012;44(11):665-673
This study aimed to determine whether taurine supplementation improves metabolic disturbances and diabetic complications in an animal model for type 2 diabetes. We investigated whether taurine has therapeutic effects on glucose metabolism, lipid metabolism, and diabetic complications in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term duration of diabetes. Fourteen 50-week-old OLETF rats with chronic diabetes were fed a diet supplemented with taurine (2%) or a non-supplemented control diet for 12 weeks. Taurine reduced blood glucose levels over 12 weeks, and improved OGTT outcomes at 6 weeks after taurine supplementation, in OLETF rats. Taurine significantly reduced insulin resistance but did not improve beta-cell function or islet mass. After 12 weeks, taurine significantly decreased serum levels of lipids such as triglyceride, cholesterol, high density lipoprotein cholesterol, and low density lipoprotein cholesterol. Taurine significantly reduced serum leptin, but not adiponectin levels. However, taurine had no therapeutic effect on damaged tissues. Taurine ameliorated hyperglycemia and dyslipidemia, at least in part, by improving insulin sensitivity and leptin modulation in OLETF rats with long-term diabetes. Additional study is needed to investigate whether taurine has the same beneficial effects in human diabetic patients.
Adipokines/blood
;
Animals
;
Blood Glucose
;
Diabetes Mellitus, Type 2/drug therapy
;
Dietary Supplements
;
Dyslipidemias/blood/*drug therapy
;
Glucose Tolerance Test
;
Hyperglycemia/blood/*drug therapy
;
Hypoglycemic Agents/administration & dosage/*pharmacology
;
Hypolipidemic Agents/administration & dosage/*pharmacology
;
Insulin/physiology/secretion
;
Insulin Resistance
;
Insulin-Secreting Cells/physiology/secretion
;
Leptin/*blood
;
Lipid Metabolism/drug effects
;
Lipids/blood
;
Male
;
Organ Specificity
;
Rats
;
Rats, Long-Evans
;
Taurine/administration & dosage/*pharmacology
2.Inhibition of Neointima Formation and Migration of Vascular Smooth Muscle Cells by Anti-vascular Endothelial Growth Factor Receptor-1 (Flt-1) Peptide in Diabetic Rats.
Min Seop JO ; Ki Dong YOO ; Chan Beom PARK ; Deog Gon CHO ; Kue Do CHO ; Ung JIN ; Kun Woong MOON ; Chul Min KIM ; Sun Hee LEE ; Young Pil WANG
The Korean Journal of Thoracic and Cardiovascular Surgery 2007;40(4):264-272
BACKGROUND: Vascular endothelial growth factor (VEGF) plays an important role in angiogenesis, including stimulating the proliferation and migration of vascular smooth muscle cells (VSMCs). It has been known that diabetes is associated with accelerated cellular proliferation via VEGF, as compared to that under a normal glucose concentration. We investigated the effects of selective blockade of a VEGF receptor by using anti-Flt-1 peptide on the formation and hyperplasia of the neointima in balloon injured-carotid arteries of OLETF rats and also on the in vitro VSMCs' migration under high glucose conditions. MATERIAL AND METHOD: The balloon-injury method was employed to induce neointima formation by VEGF. For 14 days beginning 2 days before the ballon injury, placebo or vascular endothelial growth factor receptor-1 (VEGFR-1) specific peptide (anti-Flt-1 peptide), was injected at a dose of 0.5 mg/kg daily into the OLETF rats. At 14 days after balloon injury, the neointimal proliferation and vascular luminal stenosis were measured, and cellular proliferation was assessed by counting the proliferative cell nuclear antigen (PCNA) stained cells. To analyze the effect of VEGF and anti-Flt-1 peptide on the migration of VSMCs under a high glucose condition, transwell assay with a matrigel filter was performed. And finally, to determine the underlying mechanism of the effect of anti-Flt-1 peptide on the VEGF-induced VSMC migration in vitro, the expression of matrix metalloproteinase (MMP) was observed by performing reverse transcription-polymerase chain reaction (RT-PCR). RESULT: Both the neointimal area and luminal stenosis associated with neointimal proliferation were significantly decreased in the anti-Flt-1 peptide injected rats, (0.15+/-0.04 mm2 and 36.03+/-3.78% compared to 0.24+/-0.03 mm2 and 61.85+/-5.11%, respectively, in the placebo-injected rats (p<0.01, respectively). The ratio of PCNA(+) cells to the entire neointimal cells was also significantly decreased from 52.82+/-4.20% to 38.11+/-6.89% by the injected anti-Flt-1 peptide (p<0.05). On the VSMC migration assay, anti-Flt-1 peptide significantly reduced the VEGF-induced VMSC migration by about 40% (p<0.01). Consistent with the effect of anti-Flt-1 peptide on VSMC migration, it also obviously attenuated the induction of the MMP-3 and MMP-9 mRNA expressions via VEGF in the VSMCs. CONCLUSION: Anti-Flt-1 peptide inhibits the formation and hyperplasia of the neointima in a balloon-injured carotid artery model of OLETF rats. Anti-Flt-1 peptide also inhibits the VSMCs' migration and the expressions of MMP-3 and MMP-9 mRNA induced by VEGF under a high glucose condition.
Animals
;
Arteries
;
Carotid Arteries
;
Cell Proliferation
;
Constriction, Pathologic
;
Endothelial Growth Factors*
;
Glucose
;
Hyperplasia
;
Muscle, Smooth, Vascular*
;
Neointima*
;
Phenobarbital
;
Rats*
;
Rats, Inbred OLETF
;
Receptors, Vascular Endothelial Growth Factor
;
RNA, Messenger
;
Vascular Endothelial Growth Factor A
;
Vascular Endothelial Growth Factor Receptor-1
3.Eisenmenger syndrome in pregnancy at second and third trimester.
Kue Hyun KANG ; Byoung Jae KIM ; Yoo Kyung SOHN ; Si Eun LEE ; Mi Kyung KIM ; Soon Sup SHIM ; Joong Shin PARK ; Jong Kwan JUN ; Bo Hyun YOON ; Hee Chul SYN
Korean Journal of Obstetrics and Gynecology 2006;49(4):831-839
OBJECTIVE: Because women with Eisenmenger syndrome are counseled strongly not to conceive, pregnancy cases with Eisenmenger syndrome are rare in clinical situation. We performed this study to analyze pregnancies at second and third trimester complicated by Eisenmenger syndrome and to evaluate changes during pregnancy and their outcomes. METHODS: Medical records were reviewed retrospectively for Eisenmenger syndrome patients who delivered at second and third trimester at Seoul National University Hospital from January 1989 to October 2005. RESULTS: Among the total of 6 pregnant women, 4 women delivered after 34 weeks and 2 women had therapeutic termination during second trimester. All 4 women who delivered after 34 weeks were categorized as class III by New York Heart Association classification. Maternal mortality rate was 33% (2 of 6 cases). All mortality cases were patients who delivered after 34 weeks. All neonates were small for gestational age with no neonatal death. There was no neonatal morbidity except one case of congenital atrial septal defect. CONCLUSION: Maternal mortality occurred in half of the women who continued their pregnancy beyond second trimester. We think that pregnancy should be still discouraged in patients with Eisenmenger syndrome and that therapeutic abortion should be offered in early pregnancy period.
Abortion, Therapeutic
;
Classification
;
Eisenmenger Complex*
;
Female
;
Gestational Age
;
Heart
;
Heart Septal Defects, Atrial
;
Humans
;
Infant, Newborn
;
Maternal Mortality
;
Medical Records
;
Mortality
;
Pregnancy Outcome
;
Pregnancy Trimester, Second
;
Pregnancy Trimester, Third*
;
Pregnancy*
;
Pregnant Women
;
Retrospective Studies
;
Seoul
4.Perinatal Outcomes of Triplet Pregnancies.
Soo Jin CHAE ; Won Jeong YOO ; Kue Hyun KANG ; Byoung Jae KIM ; Si Eun LEE ; Yoo Kyung SOHN ; Soon Sup SHIM ; Joong Shin PARK ; Jong Kwan JUN ; Bo Hyun YOON ; Hee Chul SYN
Korean Journal of Obstetrics and Gynecology 2006;49(5):1051-1059
OBJECTIVE: To evaluate the perinatal outcomes and maternal complications associated with triplet pregnancies. METHODS: Medical records of consecutive triplet pregnancies delivered in ( )( )Hospital from 1997 to 2005 were reviewed for maternal and neonatal outcomes. Pregnancies associated with lethal congenital anomalies or the case that being delivered before 20 weeks of gestation were excluded. Neonatal outcomes included respiratory distress syndrome, retinopathy of prematurity, necrotizing enterocolitis, intraventricular hemorrhage and low Apgar scores, congenital anomaly and so on. Maternal outcomes included preeclampsia, preterm delivery, anemia and blood transfusion and so on. RESULTS: The mean gestational age at delivery was 31.5+/-4.1 weeks, and the mean birth weight for triplets was 1,654.4+/-578.1 g. 31 of total 39 neonates (79.5%) were admitted to the neonatal intensive care unit, and 9 neonates (23.1%) received mechanical ventilator care as well. Neonatal death occurred in 6 of 39 neonates (15.4%). Congenital anomaly was seen in 3 of 39 neonates (7.7%). Hyperbilirubinemia developed in 16 of 39 neonates (44.4%). Respiratory distress syndrome developed in 3 of 39 neonates (7.7%). The most common maternal complication was preterm labor (76.9%), followed by anemia (46.1%), preterm premature rupture of membrane (30.8%) and blood transfusion (7.7%). Five patients (5/13, 38.5%) received tocolytic therapy. CONCLUSION: The main cause of neonatal death in triplet pregnancies is the respiratory distress syndrome in extreme preterm delivery. The most common neonatal morbidities are hyperbilirubinemia and apnea of prematurity. There is no difference in neonatal outcomes according to birth order. The most common maternal complications are preterm delivery and anemia. The adverse outcomes of triplet pregnancies are mainly due to preterm delivery.
Anemia
;
Apnea
;
Birth Order
;
Birth Weight
;
Blood Transfusion
;
Enterocolitis, Necrotizing
;
Female
;
Gestational Age
;
Hemorrhage
;
Humans
;
Hyperbilirubinemia
;
Infant, Newborn
;
Intensive Care, Neonatal
;
Medical Records
;
Membranes
;
Obstetric Labor, Premature
;
Pre-Eclampsia
;
Pregnancy
;
Pregnancy, Triplet*
;
Retinopathy of Prematurity
;
Rupture
;
Tocolysis
;
Triplets*
;
Ventilators, Mechanical
5.Perinatal Outcomes of Triplet Pregnancies.
Soo Jin CHAE ; Won Jeong YOO ; Kue Hyun KANG ; Byoung Jae KIM ; Si Eun LEE ; Yoo Kyung SOHN ; Soon Sup SHIM ; Joong Shin PARK ; Jong Kwan JUN ; Bo Hyun YOON ; Hee Chul SYN
Korean Journal of Obstetrics and Gynecology 2006;49(5):1051-1059
OBJECTIVE: To evaluate the perinatal outcomes and maternal complications associated with triplet pregnancies. METHODS: Medical records of consecutive triplet pregnancies delivered in ( )( )Hospital from 1997 to 2005 were reviewed for maternal and neonatal outcomes. Pregnancies associated with lethal congenital anomalies or the case that being delivered before 20 weeks of gestation were excluded. Neonatal outcomes included respiratory distress syndrome, retinopathy of prematurity, necrotizing enterocolitis, intraventricular hemorrhage and low Apgar scores, congenital anomaly and so on. Maternal outcomes included preeclampsia, preterm delivery, anemia and blood transfusion and so on. RESULTS: The mean gestational age at delivery was 31.5+/-4.1 weeks, and the mean birth weight for triplets was 1,654.4+/-578.1 g. 31 of total 39 neonates (79.5%) were admitted to the neonatal intensive care unit, and 9 neonates (23.1%) received mechanical ventilator care as well. Neonatal death occurred in 6 of 39 neonates (15.4%). Congenital anomaly was seen in 3 of 39 neonates (7.7%). Hyperbilirubinemia developed in 16 of 39 neonates (44.4%). Respiratory distress syndrome developed in 3 of 39 neonates (7.7%). The most common maternal complication was preterm labor (76.9%), followed by anemia (46.1%), preterm premature rupture of membrane (30.8%) and blood transfusion (7.7%). Five patients (5/13, 38.5%) received tocolytic therapy. CONCLUSION: The main cause of neonatal death in triplet pregnancies is the respiratory distress syndrome in extreme preterm delivery. The most common neonatal morbidities are hyperbilirubinemia and apnea of prematurity. There is no difference in neonatal outcomes according to birth order. The most common maternal complications are preterm delivery and anemia. The adverse outcomes of triplet pregnancies are mainly due to preterm delivery.
Anemia
;
Apnea
;
Birth Order
;
Birth Weight
;
Blood Transfusion
;
Enterocolitis, Necrotizing
;
Female
;
Gestational Age
;
Hemorrhage
;
Humans
;
Hyperbilirubinemia
;
Infant, Newborn
;
Intensive Care, Neonatal
;
Medical Records
;
Membranes
;
Obstetric Labor, Premature
;
Pre-Eclampsia
;
Pregnancy
;
Pregnancy, Triplet*
;
Retinopathy of Prematurity
;
Rupture
;
Tocolysis
;
Triplets*
;
Ventilators, Mechanical
6.Primary Invasive Vulvar Cancer, Retrospective Study of 23 cases.
Shin Wha LEE ; Min Hyung JUNG ; Kue Rye KIM ; Hang Jo YOO ; Dae Yeon KIM ; Jong Hyeok KIM ; Yong Man KIM ; Young Tak KIM ; Joo Hyun NAM ; Jung Eun MOK
Korean Journal of Obstetrics and Gynecology 2005;48(3):589-596
OBJECTIVE: The vulvar cancer is an uncommon disease among female population. Because of its rare incidence, sufficient clinical studies have not been accomplished. However, the prevelance of vulvar cancer will continue to increase because of rapid growth of senile population. The goal of this study is to review the clinical outcome and prognosis of patients with vulvar cancer through the analysis of their clinical data. METHODS: We have performed a retrospective clinical study on 23 patients diagnosed with primary invasive vulvar cancer at Asan medical center from May, 1989 to December, 2003. We reviewed demographic data, pathologic findings, treatments, stages, complications, prognosis and survival time. RESULTS: The mean age was 58.9 years. The most common symptoms were palpable mass (69.5%) and itching sense (21.7%). Among the 23 patients, 21 patients have underwent operation, and two patients who refused to receive operation underwent radiotherapy only. 3 of 21 patients who were surgically treated underwent neoadjuvant chemotherapy, and 5 patients, adjuvant radiotherapy. Histopathologically, squamous cell carcinoma (69.5%) was dominant, and 15 patients turned out to have stage II disease or greater (60.8%). Among the 21 patients who have underwent operation, postoperative complications occurred in 8 patients (38.0%) and 4 of them had underwent radical vulvectomy and bilateral groin lymph node dissection. The most common postoperative complication was wound breakdown (23.8%). CONCLUSION: Although surgery is the principal treatment in vulvar cancer, radical vulvectomy and bilateral groin lymph node dissection more often result in complications than other operations such as wide local excision and hemivulvectomy. Considering the mortality and morbidity, the prognosis of vulvar cancer is poor, but early diagnosis and adequate treatment according to each individual will improve the outcome and prognosis of vulvar cancer.
Carcinoma, Squamous Cell
;
Chungcheongnam-do
;
Drug Therapy
;
Early Diagnosis
;
Female
;
Groin
;
Humans
;
Incidence
;
Lymph Node Excision
;
Mortality
;
Postoperative Complications
;
Prognosis
;
Pruritus
;
Radiotherapy
;
Radiotherapy, Adjuvant
;
Retrospective Studies*
;
Vulva
;
Vulvar Neoplasms*
;
Wounds and Injuries
7.Impact of Device Evolution in Transcatheter Closure of Patent Ductus Arteriosus Using Duct-Occlud Coils: Comparison of Mid-term Results.
Myung Kwan KIM ; Dong Ki HAN ; Jae Young CHOI ; Yuria KIM ; Byung Won YOO ; Deok Young CHOI ; Jun Hee SUL ; Sung Kue LEE
Korean Journal of Pediatrics 2005;48(2):158-164
PURPOSE: We reviewed the therapeutic results of various Duct-Occlud coils(pfm AG, Koln, Germany) to evaluate the efficacy of the most-recently modified Duct-Occlud coil(Nit-Occlud) in the transcatheter closure of patent ductus arteriosus(PDA), including large defects more than 4 mm in diameter. METHODS: Two hundred and five patients who underwent percutaneous PDA occlusion using Duct- Occlud devices from March 1996 to December 2003 were enrolled and four types of Duct-Occlud [Standard(S), Reinforced(R), Reinforced reverse cone(RR) and Nit-Occlud(N)] were used in this study. The patients were followed up by echocardiogram and physical examination before discharge, one month, six months and 12 months after the procedure. RESULTS: The rate of residual shunt according to the type of Duct-Occlud were as follows: S-54%, R-72%, RR-50%, N-14%(P<0.05 compared with other devices) at one month, S-25%, R-44%, RR- 37%, N-0%(P<0.05 compared with other devices) at six months, S-8%, R-8%, RR-4%, N-0%(P< 0.05 compared with S and R) at 12 months and later. Nit-Occlud coil showed the complete occlusion of PDA after six months of follow-up, even in 12 patients with relatively large PDA(>4 mm). CONCLUSION: The transcatheter closure of PDA using Duct-Occlud was an effective treatment and our study revealed that a Nit-Occlud coil which showed higher rate of occlusion even in PDA with large diameters over than 4 mm, was a more effective modality compared to previous devices.
Ductus Arteriosus, Patent*
;
Follow-Up Studies
;
Humans
;
Physical Examination
8.Liver Abscess Caused by Gemella morbillorum.
Hyo Jung NAM ; Sang Jeong YOON ; Byung Min JOHN ; Sung Hee JUNG ; Anna KIM ; Byeong Seong KO ; Hyeon Woong YANG ; Kue Yup HWANG ; Jung Yoon LEE ; Sae Hee KIM ; Dong Jin KIM ; Nae Yoo KIM ; Sin Hyung LIM
The Korean Journal of Gastroenterology 2005;46(1):56-59
Gemella morbillorum, an anaerobic-to-aerotolerant Gram-positive coccus, is a normal flora of the oral cavity, respiratory tract, urogenital organ and gastrointestinal tract, and infections caused by this organism are unusual. It has been associated mainly with endocarditis and bacteremia, and rarely with arthritis, spondylodiscitis, meningitis, brain abscess and septic shock. Liver abscess caused by G. morbillorum is very rare, and only a few cases were reported. We experienced a case of liver abscess by G. morbillorum in a 56-year-old woman presented with fever. We report this case with a review of literatures.
Female
;
Gram-Positive Bacterial Infections/*diagnosis
;
Humans
;
Liver Abscess/diagnosis/*microbiology
;
Middle Aged
;
*Staphylococcaceae
;
Tomography, X-Ray Computed
9.Insufficiency Fracture of Olecranon after Total Elbow Replacement Arthroplasty in Rheumatoid Arthritis: Report of Three Cases.
Yoo Joon SUH ; Seok Whan SONG ; Seung Koo RHEE ; Man Kue BAE
The Journal of the Korean Orthopaedic Association 2005;40(1):89-94
Osteoporosis due to the rheumatoid arthritis and the glucocorticoid therapy predisposes patients to insufficiency fractures. Insufficiency fractures or periprosthetic fractures of the lower extremity in the rheumatoid arthritis have been frequently reported. But those of the upper extremity were rarely reported. We report three cases of the insufficiency fracture of the olecranon after total elbow replacement arthroplasty in patients with the rheumatoid arthritis. All the cases were successfully treated by immobilization for 3 weeks. At the last follow-up, there were no functional impairments or residual symptoms caused by the fractures.
Arthritis, Rheumatoid*
;
Arthroplasty*
;
Arthroplasty, Replacement, Elbow*
;
Follow-Up Studies
;
Fractures, Stress*
;
Humans
;
Immobilization
;
Lower Extremity
;
Olecranon Process*
;
Osteoporosis
;
Periprosthetic Fractures
;
Upper Extremity
10.Two Cases of Cerebral Infarctions Complicated by Streptococcus pneumoniae Meningitis.
Ji Young KIM ; Mee So JUNG ; Sung Kue LEE ; Ho Jin PARK ; In Kue YOO
Journal of the Korean Child Neurology Society 2004;12(2):207-212
Despite the advent of new antimicrobial drugs and mordern imaging techniques, mortality and morbidity of bacterial meningitis remain high. The unfavorable clinical outcomes are due to intracranial complications such as cerebrovascular complications, hydrocephalus, cerebral edema, intracerebral hemorrhage, brain abscess, and convulsion. Prompt identification and treatment of each are essential to mininize unfavorable outcomes. We report two cases of cerebral infarctions complicated by Streptococcus pneumoniae meningitis with a brief review of related literatures.
Brain Abscess
;
Brain Edema
;
Cerebral Hemorrhage
;
Cerebral Infarction*
;
Hydrocephalus
;
Meningitis, Bacterial
;
Meningitis, Pneumococcal*
;
Mortality
;
Seizures
;
Streptococcus pneumoniae*
;
Streptococcus*
;
Thrombosis

Result Analysis
Print
Save
E-mail